Coho Partners, Ltd. Amgen Inc Transaction History

Coho Partners, Ltd.

$2.84 Billion
Q2 2024

A detailed history of Coho Partners, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Coho Partners, Ltd. holds 396,628 shares of AMGN stock, worth $127 Million. This represents 4.36% of its overall portfolio holdings.

Number of Shares

396,628

Previous 456,642 13.14%

Holding current value

$127 Million

Previous $130 Million 4.55%

% of portfolio

4.36%

Previous 3.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $15.8 Million - $19.2 Million	-60,014 Reduced 13.14%	396,628 $124 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $12.8 Million - $15.5 Million	-47,777 Reduced 9.47%	456,642 $130 Million
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $26.9 Million - $30.4 Million	-105,319 Reduced 17.27%	504,419 $145 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $13.6 Million - $16.9 Million	-62,175 Reduced 9.25%	609,738 $164 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $6.27 Million - $7.41 Million	-29,243 Reduced 4.17%	671,913 $149 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $2.02 Million - $2.46 Million	-8,955 Reduced 1.26%	701,156 $170 Million
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $25 Million - $31.8 Million	-109,303 Reduced 13.34%	710,111 $187 Million
Q3 2022 Oct 07, 2022	BUY	$224.46 - $253.15 $6.92 Million - $7.8 Million	30,829 Added 3.91%	819,414 $185 Million
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $8.7 Million - $9.68 Million	-37,717 Reduced 4.56%	788,585 $192 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $18.7 Million - $20.7 Million	85,352 Added 11.52%	826,302 $200 Million
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $10.8 Million - $12.4 Million	-54,488 Reduced 6.85%	740,950 $167 Million
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $35.6 Million - $41.7 Million	-167,752 Reduced 17.42%	795,438 $169 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $2.05 Million - $2.27 Million	-8,761 Reduced 0.9%	963,190 $235 Million
Q1 2021 Apr 20, 2021	SELL	$221.91 - $258.6 $2.63 Million - $3.07 Million	-11,869 Reduced 1.21%	971,951 $242 Million
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $15 Million - $17.8 Million	69,101 Added 7.55%	983,820 $226 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $37.3 Million - $41.5 Million	-159,002 Reduced 14.81%	914,719 $232 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $1.29 Million - $1.58 Million	6,505 Added 0.61%	1,073,721 $253 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $4.17 Million - $5.53 Million	-22,899 Reduced 2.1%	1,067,216 $216 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $3.37 Million - $4.33 Million	17,787 Added 1.66%	1,090,115 $263 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $6.44 Million - $7.71 Million	-36,981 Reduced 3.33%	1,072,328 $208 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $5.08 Million - $5.96 Million	-30,489 Reduced 2.67%	1,109,309 $204 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $4.84 Million - $5.46 Million	26,772 Added 2.41%	1,139,798 $217 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $8.14 Million - $9.5 Million	45,621 Added 4.27%	1,113,026 $217 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $4.99 Million - $5.62 Million	-26,904 Reduced 2.46%	1,067,405 $221 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $5.2 Million - $5.84 Million	31,312 Added 2.95%	1,094,309 $202 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $21.8 Million - $25.5 Million	128,697 Added 13.77%	1,062,997 $181 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $5.67 Million - $6.33 Million	-33,570 Reduced 3.47%	934,300 $162 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $11.2 Million - $12.8 Million	-66,781 Reduced 6.45%	967,870 $180 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,034,651	1,034,651 $0

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coho Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coho Partners, Ltd. with notifications on news.

Account

Coho Partners, Ltd. Amgen Inc Transaction History